An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum

Applications are sought for a Clinical Fellow/Clinical Radiology trainee with a completed Part 2B FRCR or equivalent in Diagnostic Radiology for Research Fellowship. The post-holder will support a Horizon 2020 Research Grant, working on the Pro-CAncer-I project.

The post-holder will be expected to become proficient in Whole Body MRI Reporting that includes high-resolution T2-weighted imaging, diffusion-weighted and dynamic contrast enhanced imaging.

This is an immersive research post in Imaging AI aimed at providing the post-holder experience of working within a multi-disciplinary research team to grow, develop, research and apply artificial intelligence and machine learning techniques in imaging.

The successful candidate will play a significant role in supporting this project, as well as undertake other innovative radiological research within the AI Imaging Hub.

For Further Information Please Contact : Ana Ribeiro AI Imaging Hub Lead, on 020 8915 6499 ana.ribeiro@rmh.nhs.uk

 

 

Highlights

ProCAncer-I at the EMUC24 in Lisbon

ProCAncer-I at the EMUC24 in Lisbon

Oct 1, 2024

The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices will comprise the scientific programme of the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24), which will take place from 7 to 10...

Third Dissemination Event of the ProCAncer-I Project in Athens

Third Dissemination Event of the ProCAncer-I Project in Athens

May 30, 2024

ProCAncer-I organised the 3rd Dissemination Event of the project at the 21st IEEE International Symposium on Biomedical Imaging, held in Athens, Greece, May 27-30, 2024. During the symposium, ProCAncer-I organised the Workshop “Integrating imaging Data and AI models...

AI in PCa imaging : The current status and future perspectives

AI in PCa imaging : The current status and future perspectives

Apr 29, 2024

Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...

Twitter feed is not available at the moment.

Stay in touch!